Overview

A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).

Status:
Completed

Trial end date:
2012-01-01

Target enrollment:

Participant gender:

Summary

Klebsiella pneumonia, inhabitant of the digestive tract, is a frequent nosocomial pathogen. It is currently the fourth most common cause of pneumonia and fifth most common cause of bacteremia in intensive care patients (1-3). The aim of the present randomized controlled trial is to assess the efficacy of non-absorbable oral antibiotics in the eradication of the KPC carrier state.

Phase:

N/A

Details

Lead Sponsor:

Rambam Health Care Campus

Treatments:

Anti-Bacterial Agents
Colistin
Gentamicins
Polymyxins